Integer Holdings (ITGR): Patience Rewarded as KKR Buyout Delivers 70%+ Premium

Heartland Value Fund's Q3 2026 letter notes Integer Holdings (ITGR) gained 61.41% YTD, closing at $126.52. KKR agreed to acquire ITGR for $127/share, a 70%+ premium to the fund's average cost. ITGR's market cap is $4.3B. The fund underperformed in Q3 due to macroeconomic concerns, with the Russell 2000 Value Index down 4.91%.

Original reporting
Published Oct 13, 2026, 2:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 2:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Integer Holdings (ITGR): Patience Rewarded as KKR Buyout Delivers 70%+ Premium — source image
Decision brief

The 30-second read

$ITGRBullishHigh
01

Why it matters

The acquisition announcement provides a clear catalyst, likely pushing the stock toward the deal price.

02

Market read

A high-premium acquisition of a mid-cap healthcare company, offering immediate trading opportunity.

03

What to watch

Potential antitrust review and financing terms may affect deal completion timeline.

Relevance 9/10Novelty 9/10Timing: today

Background

Integer Holdings (ITGR) is a medical device contract development and manufacturing organization. The stock had risen 61% YTD before the deal.

Company-level read

Ticker impact

$ITGRBullishHigh confidence
Context

KKR announced agreement to acquire Integer Holdings at $127 per share, a >70% premium to recent price.

Expected impact

likely upward pressure as market prices in the acquisition premium

Evidence & confidence

The announced acquisition price is well above current trading levels, creating immediate upside for shareholders.

Market effects

May boost sentiment for other medical device CDMOs as consolidation accelerates.

Limited to US healthcare sector, no broad regional effect.

Highlights continued private equity interest in healthcare manufacturing.

Counterpoint

Deal could face regulatory scrutiny or integration risks, tempering upside.

Key entities

  • Integer Holdings

    Medical device CDMO target of KKR acquisition.

  • KKR

    Private equity firm acquiring ITGR.

Related articles

$ITGRMed

Integer: Q3 Earnings Snapshot

Integer Holdings Corp. (ITGR) reported Q3 earnings of $15M, or 43 cents per share, and adjusted earnings of $1.34 per share, missing analysts' estimates of $1.65 per share. Revenue was $449.7M, also below expectations of $457.3M.

$ITGRHighAI 8/10

Integer Holdings Corporation Reports Third Quarter 2026 Results

Integer Holdings Corp (ITGR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Integer Holdings Corporation Reports Third Quarter 2026 Results PLANO, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended October 2, 2026. Third Quarter 2026 Highlights (compared to Thi

$ITGRHighAI 9/10

Integer shareholders approve getting acquired by KKR

Integer (ITGR) shareholders approved a $5.7B acquisition by KKR. The vote was 26,065,335 for, 10,513 against, with 1,993 abstaining. The deal, announced in August, is expected to close by the end of 2026, pending regulatory approvals. Integer is a medical device CDMO serving cardiovascular and neuromodulation markets. The company expects increased flexibility and long-term capital as a KKR portfolio company.